Anzeige
❌
Mehr »
Montag, 28.09.2026 - Börsentäglich über 12.000 News
Zwei kanadische Investmentbanken covern diese Aktie - Beide stufen sie mit Buy ein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
576 Leser
Artikel bewerten:
(2)

Cloud DX Inc.: Cloud DX Appoints New Board Member

Dr. Gaurav Puri, Chief of Emergency Medicine at Southlake Regional Health Centre joins Cloud DX's board of directors

KITCHENER, ON / ACCESSWIRE / September 1, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading digital health platform and provider of virtual and remote patient monitoring solutions, today announced the appointment of Gaurav Puri, M.D., to the board as an independent director, effective September 1, 2022.

With over 11 years of emergency medicine experience, Dr. Puri is the current Chief of the Department of Emergency Medicine at Southlake Regional Health Centre and a lecturer at the University of Toronto, both in Ontario, Canada. He holds an Honours BSc from York University and earned his Doctor of Medicine from the University of Western Ontario. Upon completing his residency in family medicine at the University of Toronto, he completed his emergency medicine fellowship at McMaster University. Dr. Puri is a medical advisor to Able Innovations and business development advisor to Piiva.

"We're very pleased to welcome Dr. Puri to our Board," says Cloud DX Founder, CEO, and Board Chair Robert Kaul. "His experience brings tremendous leadership in the medical field and a track record of advising high-growth medical technology companies, making him a perfect fit for Cloud DX at this stage of our growth."

Cloud DX Co-founder Dr. Sonny Kohli is transitioning a portion of his clinical work to lead Medical and Regulatory affairs at Roche Canada and support digital health transformation at the global pharmaceutical leader. To serve as a senior executive at another public company, Dr. Kohli will step down from Cloud DX's Board of Directors and the Chief Medical Officer position. He will continue as Medical Co-Founder at Cloud DX.

"We're deeply grateful for the incredible contributions of Dr. Kohli as a Director and Officer of Cloud DX and we're pleased he remains our Medical Co-founder. We wish him success in the next phase of his amazing career and are excited to see how his vision and passion for the future of healthcare will support Roche Canada," says Kaul.

Dr. Kohli states, "I am thrilled to take on a new role at Roche Canada and to put to work all the lessons I've learned in 12 years of dedication as a digital health innovator. The highlight of this MedTech entrepreneurial journey has been what Robert, Tony and I have built at Cloud DX. I am immensely proud to be a part of this remarkable organization. As Cloud DX is now a well-established Canadian leader in remote patient monitoring, I am humbled and proud to behold our technology become standard of care for patients across Canada and beyond."

Dr. Puri's appointment is subject to approval by the Toronto Venture Exchange.

About Cloud DX

Accelerating digital healthcare, Cloud DX is on a mission to make healthcare better for everyone. Our Connected Health TM remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home. Our partners achieve better healthcare and patient outcomes, reduce the need for hospitalization or re-admission, and reduce healthcare delivery costs through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, 2022 Top Innovator by Canadian Business, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers." Cloud DX is an exclusive partner to Medtronic Canada, Teladoc Health Canada, and Equitable Life of Canada.

Cloud DX Investor Site https://ir.clouddx.com/overview/default.aspx

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cloud DX Inc., Thursday, September 1, 2022, Press release picture

Social Links

Twitter https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries please contact:

Janine Scott
Marketing Lead
888-543-0944
janine.scott@CloudDX.com

For investor inquiries (Canada):

Jay Bedard
Cloud DX Investor Relations
647-881-8418
investors@CloudDX.com

For investor inquiries (US):

Gary Zwetchkenbaum
Plumtree LLC
Phone 718-224-3123
Cell 516-455-7662
ir@CloudDX.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/713958/Cloud-DX-Appoints-New-Board-Member

© 2022 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.